WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 15-Jul-2018 (data as of 15-Jul-2018)
Next overall update Winter 2018
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 18'1601 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 36'9161 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 10'618  10'611  10'604  10'599  10'594  10'290  10'341  10'349 
Births 108  108  109  110  111  88  127  163 
Surviving infants 107  108  109  110  111  88  125  161 
Pop. less than 5 years 529  534  552  560  570  447  647  896 
Pop. less than 15 years 1'632  1'615  1'604  1'582  1'560  1'690  2'229  2'422 
Female 15-49 years 2'409  2'426  2'443  2'465  2'487  2'610  2'582  2'442 

Number of reported cases

(Click for retrospective incidence data for Czech Republic)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  142  222  15  2'420 
Mumps
ChartChart
  1'407  5'734  1'616  677  1'553  120 
Pertussis
ChartChart
  667  627  585  2'521  1'233  187  48 
Polio*
ChartChart
 
Rubella
ChartChart
  743 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Czech Republic)
Vaccine year result method % card seen                                                
BCG          99 
DTP1         
DTP3          96  97  98 
DTP4          94  96  97  99 
IPV1         
HepB_BD         
HepB3          94  96  97  99  99 
Hib3          94  96  97  99  99 
JapEnc         
MCV1          97  98  99 
MCV2          90  93  99  96  99  97 
MenA         
PCV1         
PCV2         
PCV3         
Pol3          94  96  97  99  99  97 
Rota1         
RotaC         
RCV1          97  98  99  99  99 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2019

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Czech Republic)
BCG
ChartChart
  98 
DTP1
ChartChart
  98  98  99  99  99  99 
DTP3
ChartChart
  96  96  97  97  98  98 
HepB3
ChartChart
  94  96  97  99  99 
HepB_BD
 
Hib3
  94  96  97  99  99 
MCV1
ChartChart
  97  98  99  99  99  97 
MCV2
ChartChart
  90  93  99  96  99  98 
PCV3
 
Pol3
  94  96  97  99  99  98 
RCV1
ChartChart
  97  98  99  99  99  97 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.


Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 4 weeks; No only in cases indicated by health professionals,basic rules are given by ministerial decree
DTaP 5 years; Yes
DTaPHibHepBIPV 9 weeks; 5, 11 months; Yes
DTaPHibHepIPV 9, 13, 17 weeks; 18 months; Yes
DTaPIPV 10 years; Yes
HPV 13 years (x2); Yes male and female
Influenza_Adult Yes elderly, adults with chronic illness, pregnant women, health care workers, residents living in long-term care facilities
Influenza_Pediatric Yes children with chronic illness
MMR 15 months; 5 years; Yes
TT 25 years; Yes each 10-15 years

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number     3 years    3 years  3 years  3 years 
Nº of districts with microplans that include activities to raise immunization coverage number     86  86  86  86  86 

System performance

Total Nº districts in country number 86  86  76  86  86  86  86 
Nº districts with DTP3 coverage >=80% number   83  86  86  86  86   
% of districts with DTP3 coverage >=80% From 0 to 100%   97  113  100  100  100   
Nº districts with measles (MCV1) coverage >=95% number       84  84  86   
% of districts with MCV1 coverage >=95% From 0 to 100%       98  98  100   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No    No   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%           NA   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2018 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2018, data for 2016
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.